Renal & Urology News: PSMA-PET Nomograms May Improve Risk Stratification Across Prostate Cancer Spectrum Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management. After months of treatment, Patrick Tafoya is now cancer-free following a battle with stage 3 prostate cancer, marking a major milestone in a year filled with medical challenges. Tafoya recently ...
Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ... Renal & Urology News: Prostate Cancer Stage Increasing, Survival Gains Slowing in the United States One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society. In the US, advanced prostate cancer diagnoses ...
prostate cancer staging, Men's Journal on MSN: 1 in 8 men will face prostate cancer—but taking this simple step for early detection can save lives 1 in 8 men will face prostate cancer—but taking this simple step for early detection can save lives BikeRadar: How Sir Chris Hoy's devastating prostate cancer diagnosis sparked a conversation about national screening The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily? How Sir Chris Hoy's devastating prostate cancer diagnosis sparked a conversation about national screening AOL: Sky News' Dermot Murnaghan shares stage 4 prostate cancer diagnosis and issues treatment update Veteran news presenter Dermot Murnaghan has revealed that he has been diagnosed with stage 4 prostate cancer. Murnaghan, who has presented news across the BBC, ITV, Channel 4 and Sky, as well as ... Sky News' Dermot Murnaghan shares stage 4 prostate cancer diagnosis and issues treatment update WGN-TV: Rise in late-stage prostate cancer: What to know about screening guidelines Medical Xpress on MSN: PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all other treatment options, a new study now demonstrates that the therapy is ...
prostate cancer staging, Medscape: Are Transdermal Oestradiol Patches a Viable Alternative to LHRH Agonists for Locally Advanced Prostate Cancer? Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows. Are Transdermal Oestradiol Patches a Viable Alternative to LHRH Agonists for Locally Advanced Prostate Cancer?
